IMC Germany’s accelerated growth potential leans strongly on its supply strategy through its ability to partner with cannabis growers for EU-GMP certification, bolstering the company’s supply...
Through continuous, active cost management, IMC reduced its annual G&A costs by 49% in 2023 and is now looking to significantly reduce its financial costs. TORONTO...
With Germany delivering accelerated growth after legalization, IMC is keeping all options open to maximize shareholder value TORONTO and GLIL YAM, Israel, May 28, 2024 /PRNewswire/...
HERZLIYA, Israel and CALGARY, AB, May 27, 2024 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the “Company” or “Innocan”), a pharmaceutical technology...
CHICAGO, May 23, 2024 /PRNewswire/ — Cannabis Testing Market in terms of revenue was estimated to be worth $1.8 billion in 2024 and is poised to reach $4.0...